{"id":45,"date":"2021-09-17T22:35:41","date_gmt":"2021-09-17T22:35:41","guid":{"rendered":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/dr-matthew-j-matasar\/"},"modified":"2023-06-14T13:09:50","modified_gmt":"2023-06-14T11:09:50","slug":"dr-matthew-j-matasar","status":"publish","type":"experts","link":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/dr-matthew-j-matasar\/","title":{"rendered":"Dr Matthew J. Matasar"},"content":{"rendered":"<p>Dr Matthew Matasar is a board-certified medical oncologist\/hematologist, who received his undergraduate and medical degrees from Harvard University. His internal medicine training was completed at Columbia Presbyterian, where he earned a Master\u2019s in biostatistics, while serving as Chief Resident. His fellowship training was in medical oncology at Memorial Sloan Kettering Cancer Center, where he subsequently joined faculty on the Lymphoma and Adult BMT services. Dr Matasar is also the Director of the Lymphoma Survivorship Clinic, where he focuses on the management of long-term survivors of Hodgkin and non-Hodgkin lymphoma. As the Section Head for Aggressive B-cell Lymphomas, his research is focused on improving outcomes in relapsed but curable patients using novel therapies. He is the Medical Director at MSK Bergen, directing a team of expert oncologists in the delivery of cutting-edge care across cancer service lines to patients at the free-standing outpatient center in Montvale, New Jersey.<\/p>\n","protected":false},"author":{"id":1,"first_name":"Francisco","nickname":"Superadmin","email":"jose.santos@cor2ed.com"},"featured_media":44,"menu_order":304,"template":"","groups":[23],"class_list":["post-45","experts","type-experts","status-publish","has-post-thumbnail","hentry","groups-lymphoma-connect"],"expert_info_prefix":"Dr","expert_info_first-name":"Matthew J.","expert_info_last-name":"Matasar","expert_info_institution":"Rutgers Cancer Institute of New Jersey","expert_info_country":"US","expert_info_specialization":"Medical Oncologist and Haematologist","expert_info_map-code":"","expert_info_disclosures":"<p>Bayer, Bayer Pharmacyclics, Genentech, GlaxoSmithKline, Immunovaccine Tech, Janssen, Juno Theraputics, Merck, Roche Rocket Medical, Seattle Genetics, Teva and Takeda.<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>&nbsp;<\/p>\r\n<p>&nbsp;<\/p>","expert_info_linkedin":"","expert_info_twitter":"","expert_info_instagram":"","expert_info_facebook":"","_links":{"self":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/45","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/types\/experts"}],"version-history":[{"count":3,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/45\/revisions"}],"predecessor-version":[{"id":89157,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/45\/revisions\/89157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media\/44"}],"wp:attachment":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media?parent=45"}],"wp:term":[{"taxonomy":"groups","embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/groups?post=45"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}